ALKS 3831 is composed of samidorphan, a mu-opioid receptor antagonist, which is co-formulated with the established antipsychotic agent, olanzapine, in a single bilayer tablet.
This study investigates whether contralateral delay activity occurs early in schizophrenia, possibly indicating that visual short-term memory deficits are a core feature of the disorder.
Researchers performed a double-blind randomized study to investigate the efficacy of tDCS as an augmentation strategy to sertraline in the treatment of vascular depression.
This study examines whether pretreatment brain activation during cognitive control and reward processing is associated with treatment response to CBT in patients with OCD.
Patients received 40 Hz gamma tACS to provide data on the use of varying stimulation periods.
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Untreated stress amongst healthcare professionals can lead to a multitude of issues while prolonged stress can contribute to burnout. In order to ensure the safety of both clinicians and patients, effective and feasible interventions are needed for individuals and organizations.
The use of cannabis in the past month among US adults with depression increased from 2005 to 2016.
Using phenotypic and genomic data from more than 100,000 participants, researchers systematically screened and validated a wide range of potential modifiable factors for depression.